Morgan Stanley’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $24.8M | Buy |
|
|||||
|
2020
Q4 | $707K | Buy |
|
|||||
|
2020
Q3 | $69K | Sell |
|
|||||
|
2020
Q2 | $139K | Sell |
|
|||||
|
2020
Q1 | $136K | Buy |
|
|||||
|
2019
Q4 | $237K | Sell |
|
|||||
|
2019
Q3 | $624K | Sell |
|
|||||
|
2019
Q2 | $1.56M | Buy |
|
|||||
|
2019
Q1 | $273K | Sell |
|
|||||
|
2018
Q4 | $718K | Buy |
|
|||||
|
2018
Q3 | $923K | Sell |
|
|||||
|
2018
Q2 | $1.58M | Buy |
|
|||||
|
2018
Q1 | $1.63M | Sell |
|
|||||
|
2017
Q4 | $7.71M | Buy |
|
|||||
|
2017
Q3 | $2.18M | Sell |
|
|||||
|
2017
Q2 | $4.12M | Buy |
|
|||||
|
2017
Q1 | $4.4M | Buy |
|
|||||
|
2016
Q4 | $5.41M | Buy |
|
|||||
|
2016
Q3 | $1.71M | Buy |
|
|||||
|
2016
Q2 | $411K | Sell |
|
|||||
|
2016
Q1 | $2.15M | Buy |
|
|||||
|
2015
Q4 | $440K | Sell |
|
|||||
|
2015
Q3 | $175K | Sell |
|
|||||
|
2015
Q2 | $485K | Sell |
|
|||||
|
2015
Q1 | $1.76M | Buy |
|
|||||
|
2014
Q4 | $184K | Sell |
|
|||||
|
2014
Q3 | $269K | Buy |
|
|||||
|
2014
Q2 | $280K | Buy |
|
|||||
|
2014
Q1 | $106K | Buy |
|
|||||
|
2013
Q4 | $8K | Buy |
|